In our series sPD-L1 is higher in controls than in patients with CCRCC and the level of sPD-L1 in cancer patients is associated with metastatic disease, but not with conventional prognosticators of CCRCC. This evidence concerns the gene SPDL1 and nonpapillary renal cell carcinoma.